Silvia Graziani

816 total citations
19 papers, 558 citations indexed

About

Silvia Graziani is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Silvia Graziani has authored 19 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cancer Research, 6 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Silvia Graziani's work include Cancer, Lipids, and Metabolism (9 papers), Neonatal Respiratory Health Research (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). Silvia Graziani is often cited by papers focused on Cancer, Lipids, and Metabolism (9 papers), Neonatal Respiratory Health Research (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). Silvia Graziani collaborates with scholars based in Brazil, Italy and Germany. Silvia Graziani's co-authors include Raul Cavalcante Maranhão, Debora Garcia Rodrigues, Roberto Hegg, Jesus Paula Carvalho, José Aristodemo Pinotti, José Cláudio Marinho da Nóbrega, Miako Kimura, Manoel Jacobsen Teixeira, Tito R. Mendoza and K.A.S.L. Ferreira and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Pediatrics and European Journal of Clinical Nutrition.

In The Last Decade

Silvia Graziani

19 papers receiving 547 citations

Peers

Silvia Graziani
Orla McNally Australia
Patrick W. Underwood United States
S. Murray Yule United Kingdom
Shadi A. Esfahani United States
Ana Miranda Portugal
Ron C. Rietbroek Netherlands
C. Sawka Canada
Silvia Graziani
Citations per year, relative to Silvia Graziani Silvia Graziani (= 1×) peers Ger‐Jan Sanderink

Countries citing papers authored by Silvia Graziani

Since Specialization
Citations

This map shows the geographic impact of Silvia Graziani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Graziani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Graziani more than expected).

Fields of papers citing papers by Silvia Graziani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Graziani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Graziani. The network helps show where Silvia Graziani may publish in the future.

Co-authorship network of co-authors of Silvia Graziani

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Graziani. A scholar is included among the top collaborators of Silvia Graziani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Graziani. Silvia Graziani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Maranhão, Raul Cavalcante, et al.. (2022). Use of paclitaxel carried in lipid core nanoparticles in patients with late-stage solid cancers with bone metastases: Lack of toxicity and therapeutic benefits. Journal of bone oncology. 34. 100431–100431. 5 indexed citations
2.
Naselli, Aldo, et al.. (2022). Early-onset fulminant neonatal sepsis caused by Multi-Drug Resistant and ESBL producing E. coli (CTX-M gene) in a late-preterm neonate: case report and literature review.. PubMed. 45(3). 223–226. 5 indexed citations
3.
Graziani, Silvia, Luca Scorrano, & Giovanna Pontarin. (2022). Transient Exposure of Endothelial Cells to Doxorubicin Leads to Long-Lasting Vascular Endothelial Growth Factor Receptor 2 Downregulation. Cells. 11(2). 210–210. 22 indexed citations
4.
Morelli, Paola, et al.. (2021). Development of a Perinatal Palliative Care Model at a Level II Perinatal Center Supported by a Pediatric Palliative Care Network. Frontiers in Pediatrics. 8. 574397–574397. 5 indexed citations
5.
Bulfamante, Gaetano, Emma Bragantini, Silvia Graziani, et al.. (2021). Generalized Arterial Calcification of Infancy Type 1 (GACI1): Identification of a Novel Pathogenic Variant (c.1715T>C (p.Leu572Ser)). Diagnostics. 11(6). 1034–1034. 4 indexed citations
7.
Maranhão, Raul Cavalcante, et al.. (2017). Clinical experience with drug delivery systems as tools to decrease the toxicity of anticancer chemotherapeutic agents. Expert Opinion on Drug Delivery. 14(10). 1217–1226. 41 indexed citations
8.
Schena, Federico, Irene Picciolli, Massimo Agosti, et al.. (2017). Perfusion Index and Pulse Oximetry Screening for Congenital Heart Defects. The Journal of Pediatrics. 183. 74–79.e1. 29 indexed citations
9.
Graziani, Silvia, et al.. (2015). Preliminary results of patients with advanced ovarian carcinoma treated with paclitaxel associated to nanoemulsions.. Journal of Clinical Oncology. 33(15_suppl). e16539–e16539. 1 indexed citations
10.
Graziani, Silvia, et al.. (2009). Uptake by breast carcinoma of a lipidic nanoemulsion after intralesional injection into the patients: A new strategy for neoadjuvant chemotherapy. Journal of Clinical Oncology. 27(15_suppl). e11555–e11555. 1 indexed citations
11.
Ferreira, K.A.S.L., Miako Kimura, Manoel Jacobsen Teixeira, et al.. (2008). Impact of Cancer-Related Symptom Synergisms on Health-Related Quality of Life and Performance Status. Journal of Pain and Symptom Management. 35(6). 604–616. 96 indexed citations
12.
Graziani, Silvia, et al.. (2008). Uptake by breast carcinoma of a lipidic nanoemulsion after intralesional injection into the patients: A new strategy for neoadjuvant chemotherapy. Gynecologic Oncology. 112(2). 400–404. 21 indexed citations
13.
Pires, Luís A., Roberto Hegg, Claudéte J. Valduga, et al.. (2008). Use of cholesterol-rich nanoparticles that bind to lipoprotein receptors as a vehicle to paclitaxel in the treatment of breast cancer: pharmacokinetics, tumor uptake and a pilot clinical study. Cancer Chemotherapy and Pharmacology. 63(2). 281–287. 55 indexed citations
14.
Carvalho, Jesus Paula, et al.. (2006). Pharmacokinetics and tumor uptake of a derivatized form of paclitaxel associated to a cholesterol-rich nanoemulsion (LDE) in patients with gynecologic cancers. Cancer Chemotherapy and Pharmacology. 59(1). 105–111. 58 indexed citations
15.
Maranhão, Raul Cavalcante, Silvia Graziani, N Yamaguchi, et al.. (2002). Association of carmustine with a lipid emulsion: in vitro, in vivo and preliminary studies in cancer patients. Cancer Chemotherapy and Pharmacology. 49(6). 487–498. 62 indexed citations
16.
Graziani, Silvia, Roberto Hegg, Laura I. Brandizzi, et al.. (2002). Uptake of a Cholesterol-Rich Emulsion by Breast Cancer. Gynecologic Oncology. 85(3). 493–497. 62 indexed citations
17.
Carvalho, Jesus Paula, et al.. (2001). Uptake of a Cholesterol-Rich Emulsion by Neoplastic Ovarian Tissues. Gynecologic Oncology. 82(1). 84–87. 54 indexed citations
18.
Zoppi, G, et al.. (1998). Respiratory quotient changes in full term newborn infants within 30 hours from birth before start of milk feeding. European Journal of Clinical Nutrition. 52(5). 360–362. 5 indexed citations
19.
Luciani, Giovanni Battista, et al.. (1993). Pulmonary valve origin of pedunculated rhabdomyoma causing moderate right ventricular outflow obstruction: surgical-implications. International Journal of Cardiology. 41(3). 233–236. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026